#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4 .
1-1	0-1	4	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Discussion
2-1	4-14	Discussion	abstract	new	_	_

#Text=The biochemical and structural analyses of a new haloalkane dehalogenase DmxA from Antarctic bacterium Marinobacter sp .
3-1	15-18	The	abstract[3]	new[3]	_	_
3-2	19-30	biochemical	abstract[3]	new[3]	_	_
3-3	31-34	and	abstract[3]	new[3]	_	_
3-4	35-45	structural	abstract[3]	new[3]	_	_
3-5	46-54	analyses	abstract[3]	new[3]	_	_
3-6	55-57	of	abstract[3]	new[3]	_	_
3-7	58-59	a	abstract[3]|abstract[5]|object[6]	new[3]|new[5]|new[6]	coref|coref	5-6[0_6]|5-6[0_6]
3-8	60-63	new	abstract[3]|abstract[5]|object[6]	new[3]|new[5]|new[6]	_	_
3-9	64-74	haloalkane	abstract[3]|object|abstract[5]|object[6]	new[3]|new|new[5]|new[6]	_	_
3-10	75-87	dehalogenase	abstract[3]|abstract[5]|object[6]	new[3]|new[5]|new[6]	_	_
3-11	88-92	DmxA	abstract[3]|abstract[5]|object[6]	new[3]|new[5]|new[6]	_	_
3-12	93-97	from	abstract[3]|abstract[5]|object[6]	new[3]|new[5]|new[6]	_	_
3-13	98-107	Antarctic	abstract[3]|abstract[5]|object[6]|animal[9]	new[3]|new[5]|new[6]|new[9]	_	_
3-14	108-117	bacterium	abstract[3]|abstract[5]|object[6]|animal|animal[9]	new[3]|new[5]|new[6]|new|new[9]	_	_
3-15	118-130	Marinobacter	abstract[3]|abstract[5]|object[6]|person|animal[9]	new[3]|new[5]|new[6]|new|new[9]	_	_
3-16	131-133	sp	abstract[3]|abstract[5]|object[6]|animal[9]	new[3]|new[5]|new[6]|new[9]	_	_
3-17	134-135	.	_	_	_	_

#Text=ELB17 revealed the paradoxical stability of the enzyme .
4-1	136-141	ELB17	abstract	new	_	_
4-2	142-150	revealed	_	_	_	_
4-3	151-154	the	abstract[11]	new[11]	ana	5-2[0_11]
4-4	155-166	paradoxical	abstract[11]	new[11]	_	_
4-5	167-176	stability	abstract[11]	new[11]	_	_
4-6	177-179	of	abstract[11]	new[11]	_	_
4-7	180-183	the	abstract[11]|object[12]	new[11]|new[12]	coref	7-1[32_12]
4-8	184-190	enzyme	abstract[11]|object[12]	new[11]|new[12]	_	_
4-9	191-192	.	_	_	_	_

#Text=Despite its psychrophilic origin , DmxA wt exhibited the highest apparent melting temperature ( T m , app = 65.9 ± 0.1 °C ) of all biochemically characterized HLD-II members , and the second highest of all thus far characterized wild-type HLDs .
5-1	193-200	Despite	_	_	_	_
5-2	201-204	its	abstract|abstract[14]	giv|new[14]	coref|coref|coref|coref	10-13[55_14]|10-25[58_0]|10-13[55_14]|10-25[58_0]
5-3	205-218	psychrophilic	abstract[14]	new[14]	_	_
5-4	219-225	origin	abstract[14]	new[14]	_	_
5-5	226-227	,	_	_	_	_
5-6	228-232	DmxA	object|abstract[16]	giv|new[16]	coref|coref|coref|coref	6-10|11-9[71_16]|6-10|11-9[71_16]
5-7	233-235	wt	abstract[16]	new[16]	_	_
5-8	236-245	exhibited	_	_	_	_
5-9	246-249	the	abstract[18]	new[18]	coref	6-5[29_18]
5-10	250-257	highest	abstract[18]	new[18]	_	_
5-11	258-266	apparent	abstract[18]	new[18]	_	_
5-12	267-274	melting	object|abstract[18]	new|new[18]	coref	6-7
5-13	275-286	temperature	abstract[18]	new[18]	_	_
5-14	287-288	(	_	_	_	_
5-15	289-290	T	person[19]	new[19]	coref	7-12[36_19]
5-16	291-292	m	person[19]|quantity	new[19]|new	_	_
5-17	293-294	,	_	_	_	_
5-18	295-298	app	quantity	new	coref	7-15
5-19	299-300	=	_	_	_	_
5-20	301-305	65.9	quantity	new	_	_
5-21	306-307	±	_	_	_	_
5-22	308-311	0.1	quantity[23]	new[23]	_	_
5-23	312-314	°C	quantity[23]	new[23]	_	_
5-24	315-316	)	_	_	_	_
5-25	317-319	of	_	_	_	_
5-26	320-323	all	_	_	_	_
5-27	324-337	biochemically	_	_	_	_
5-28	338-351	characterized	_	_	_	_
5-29	352-358	HLD-II	event|person[25]	new|new[25]	coref|coref|coref|coref	19-29[138_25]|19-34|19-29[138_25]|19-34
5-30	359-366	members	person[25]	new[25]	_	_
5-31	367-368	,	_	_	_	_
5-32	369-372	and	_	_	_	_
5-33	373-376	the	_	_	_	_
5-34	377-383	second	_	_	_	_
5-35	384-391	highest	_	_	_	_
5-36	392-394	of	_	_	_	_
5-37	395-398	all	_	_	_	_
5-38	399-403	thus	_	_	_	_
5-39	404-407	far	_	_	_	_
5-40	408-421	characterized	_	_	_	_
5-41	422-431	wild-type	substance[26]	new[26]	coref	25-8[0_26]
5-42	432-436	HLDs	substance[26]	new[26]	_	_
5-43	437-438	.	_	_	_	_

#Text=The only HLD exhibiting higher apparent melting temperature than DmxA was DhmeA from halophilic archaea Haloferax mediterranei ATCC 33500 , which belongs to the subfamily HLD-III .
6-1	439-442	The	object[27]	new[27]	coref	13-8[0_27]
6-2	443-447	only	object[27]	new[27]	_	_
6-3	448-451	HLD	object[27]	new[27]	_	_
6-4	452-462	exhibiting	_	_	_	_
6-5	463-469	higher	abstract[29]	giv[29]	coref	23-8[166_29]
6-6	470-478	apparent	abstract[29]	giv[29]	_	_
6-7	479-486	melting	object|abstract[29]	giv|giv[29]	coref	23-9
6-8	487-498	temperature	abstract[29]	giv[29]	_	_
6-9	499-503	than	abstract[29]	giv[29]	_	_
6-10	504-508	DmxA	abstract[29]|object	giv[29]|giv	coref	8-18
6-11	509-512	was	_	_	_	_
6-12	513-518	DhmeA	_	_	_	_
6-13	519-523	from	_	_	_	_
6-14	524-534	halophilic	_	_	_	_
6-15	535-542	archaea	_	_	_	_
6-16	543-552	Haloferax	_	_	_	_
6-17	553-565	mediterranei	_	_	_	_
6-18	566-570	ATCC	_	_	_	_
6-19	571-576	33500	_	_	_	_
6-20	577-578	,	_	_	_	_
6-21	579-584	which	_	_	_	_
6-22	585-592	belongs	_	_	_	_
6-23	593-595	to	_	_	_	_
6-24	596-599	the	abstract[31]	new[31]	coref	7-5[34_31]
6-25	600-609	subfamily	abstract[31]	new[31]	_	_
6-26	610-617	HLD-III	abstract[31]	new[31]	_	_
6-27	618-619	.	_	_	_	_

#Text=The enzyme DhmeA from subfamily HLD-III is a multimeric protein with T m , app = 70.6 °C .
7-1	620-623	The	substance[32]|substance[33]	giv[32]|new[33]	coref|coref|coref|coref	7-8[35_33]|15-35[106_32]|7-8[35_33]|15-35[106_32]
7-2	624-630	enzyme	substance[32]|substance[33]	giv[32]|new[33]	_	_
7-3	631-636	DhmeA	substance[33]	new[33]	_	_
7-4	637-641	from	substance[33]	new[33]	_	_
7-5	642-651	subfamily	substance[33]|abstract[34]	new[33]|giv[34]	coref	19-32[139_34]
7-6	652-659	HLD-III	substance[33]|abstract[34]	new[33]|giv[34]	_	_
7-7	660-662	is	_	_	_	_
7-8	663-664	a	substance[35]	giv[35]	coref	8-5[0_35]
7-9	665-675	multimeric	substance[35]	giv[35]	_	_
7-10	676-683	protein	substance[35]	giv[35]	_	_
7-11	684-688	with	substance[35]	giv[35]	_	_
7-12	689-690	T	substance[35]|quantity[36]	giv[35]|giv[36]	coref	23-19[0_36]
7-13	691-692	m	substance[35]|quantity[36]	giv[35]|giv[36]	_	_
7-14	693-694	,	_	_	_	_
7-15	695-698	app	abstract	giv	coref	23-22
7-16	699-700	=	_	_	_	_
7-17	701-705	70.6	quantity[38]	new[38]	_	_
7-18	706-708	°C	quantity[38]	new[38]	_	_
7-19	709-710	.	_	_	_	_

#Text=The tertiary structure of DhmeA is not available at this moment , preventing its direct comparison with DmxA .
8-1	711-714	The	abstract[39]	new[39]	coref	10-34[60_39]
8-2	715-723	tertiary	abstract[39]	new[39]	_	_
8-3	724-733	structure	abstract[39]	new[39]	_	_
8-4	734-736	of	abstract[39]	new[39]	_	_
8-5	737-742	DhmeA	abstract[39]|substance	new[39]|giv	ana	8-14
8-6	743-745	is	_	_	_	_
8-7	746-749	not	_	_	_	_
8-8	750-759	available	_	_	_	_
8-9	760-762	at	_	_	_	_
8-10	763-767	this	time[41]	new[41]	_	_
8-11	768-774	moment	time[41]	new[41]	_	_
8-12	775-776	,	_	_	_	_
8-13	777-787	preventing	_	_	_	_
8-14	788-791	its	substance|abstract[43]	giv|new[43]	coref|coref	15-4|15-4
8-15	792-798	direct	abstract[43]	new[43]	_	_
8-16	799-809	comparison	abstract[43]	new[43]	_	_
8-17	810-814	with	abstract[43]	new[43]	_	_
8-18	815-819	DmxA	abstract[43]|abstract	new[43]|giv	coref	11-9
8-19	820-821	.	_	_	_	_

#Text=Several thermostable enzymes from psychrophiles and mesophiles have been reported in the literature ; however , their unexpected thermostability remains poorly understood .
9-1	822-829	Several	abstract[45]	new[45]	coref	10-6[52_45]
9-2	830-842	thermostable	abstract[45]	new[45]	_	_
9-3	843-850	enzymes	abstract[45]	new[45]	_	_
9-4	851-855	from	abstract[45]	new[45]	_	_
9-5	856-869	psychrophiles	abstract[45]|substance	new[45]|new	_	_
9-6	870-873	and	abstract[45]	new[45]	_	_
9-7	874-884	mesophiles	abstract[45]|substance	new[45]|new	ana	9-17
9-8	885-889	have	_	_	_	_
9-9	890-894	been	_	_	_	_
9-10	895-903	reported	_	_	_	_
9-11	904-906	in	_	_	_	_
9-12	907-910	the	abstract[48]	new[48]	_	_
9-13	911-921	literature	abstract[48]	new[48]	_	_
9-14	922-923	;	_	_	_	_
9-15	924-931	however	_	_	_	_
9-16	932-933	,	_	_	_	_
9-17	934-939	their	substance|abstract[50]	giv|new[50]	_	_
9-18	940-950	unexpected	abstract[50]	new[50]	_	_
9-19	951-966	thermostability	abstract[50]	new[50]	_	_
9-20	967-974	remains	_	_	_	_
9-21	975-981	poorly	_	_	_	_
9-22	982-992	understood	_	_	_	_
9-23	993-994	.	_	_	_	_

#Text=Only two studies focused on such paradoxically thermostable enzymes from psychrophilic and mesophilic origin have attempted so far to explain the structural basis of their stability , suggesting that either the flexibility of a global structure or the presence of extra disulfide and salt bridges are responsible for the unusual thermal stability of these enzymes .
10-1	995-999	Only	abstract[51]	new[51]	_	_
10-2	1000-1003	two	abstract[51]	new[51]	_	_
10-3	1004-1011	studies	abstract[51]	new[51]	_	_
10-4	1012-1019	focused	_	_	_	_
10-5	1020-1022	on	_	_	_	_
10-6	1023-1027	such	abstract[52]	giv[52]	ana	10-25[0_52]
10-7	1028-1041	paradoxically	abstract[52]	giv[52]	_	_
10-8	1042-1054	thermostable	abstract[52]	giv[52]	_	_
10-9	1055-1062	enzymes	abstract[52]	giv[52]	_	_
10-10	1063-1067	from	abstract[52]	giv[52]	_	_
10-11	1068-1081	psychrophilic	abstract[52]|person	giv[52]|new	_	_
10-12	1082-1085	and	abstract[52]	giv[52]	_	_
10-13	1086-1096	mesophilic	abstract[52]|place|abstract[55]	giv[52]|new|giv[55]	_	_
10-14	1097-1103	origin	abstract[52]|abstract[55]	giv[52]|giv[55]	_	_
10-15	1104-1108	have	_	_	_	_
10-16	1109-1118	attempted	_	_	_	_
10-17	1119-1121	so	_	_	_	_
10-18	1122-1125	far	_	_	_	_
10-19	1126-1128	to	_	_	_	_
10-20	1129-1136	explain	_	_	_	_
10-21	1137-1140	the	abstract[56]	new[56]	_	_
10-22	1141-1151	structural	abstract[56]	new[56]	_	_
10-23	1152-1157	basis	abstract[56]	new[56]	_	_
10-24	1158-1160	of	abstract[56]	new[56]	_	_
10-25	1161-1166	their	abstract[56]|abstract|abstract[58]	new[56]|giv|giv[58]	coref|coref	10-54[67_0]|10-54[67_0]
10-26	1167-1176	stability	abstract[56]|abstract[58]	new[56]|giv[58]	_	_
10-27	1177-1178	,	_	_	_	_
10-28	1179-1189	suggesting	_	_	_	_
10-29	1190-1194	that	_	_	_	_
10-30	1195-1201	either	abstract[59]	new[59]	_	_
10-31	1202-1205	the	abstract[59]	new[59]	_	_
10-32	1206-1217	flexibility	abstract[59]	new[59]	_	_
10-33	1218-1220	of	abstract[59]	new[59]	_	_
10-34	1221-1222	a	abstract[59]|abstract[60]	new[59]|giv[60]	ana	11-17[0_60]
10-35	1223-1229	global	abstract[59]|abstract[60]	new[59]|giv[60]	_	_
10-36	1230-1239	structure	abstract[59]|abstract[60]	new[59]|giv[60]	_	_
10-37	1240-1242	or	_	_	_	_
10-38	1243-1246	the	abstract[61]	new[61]	coref	16-7[109_61]
10-39	1247-1255	presence	abstract[61]	new[61]	_	_
10-40	1256-1258	of	abstract[61]	new[61]	_	_
10-41	1259-1264	extra	abstract[61]|substance[62]	new[61]|new[62]	coref	18-4[0_62]
10-42	1265-1274	disulfide	abstract[61]|substance[62]	new[61]|new[62]	_	_
10-43	1275-1278	and	abstract[61]	new[61]	_	_
10-44	1279-1283	salt	abstract[61]|substance|object[64]	new[61]|new|new[64]	_	_
10-45	1284-1291	bridges	abstract[61]|object[64]	new[61]|new[64]	_	_
10-46	1292-1295	are	_	_	_	_
10-47	1296-1307	responsible	_	_	_	_
10-48	1308-1311	for	_	_	_	_
10-49	1312-1315	the	abstract[66]	new[66]	coref	11-17[73_66]
10-50	1316-1323	unusual	abstract[66]	new[66]	_	_
10-51	1324-1331	thermal	animal|abstract[66]	new|new[66]	_	_
10-52	1332-1341	stability	abstract[66]	new[66]	_	_
10-53	1342-1344	of	abstract[66]	new[66]	_	_
10-54	1345-1350	these	abstract[66]|abstract[67]	new[66]|giv[67]	_	_
10-55	1351-1358	enzymes	abstract[66]|abstract[67]	new[66]|giv[67]	_	_
10-56	1359-1360	.	_	_	_	_

#Text=In this study , several structural features of DmxA wt were analyzed in detail to explain its extraordinary stability .
11-1	1361-1363	In	_	_	_	_
11-2	1364-1368	this	abstract[68]	new[68]	_	_
11-3	1369-1374	study	abstract[68]	new[68]	_	_
11-4	1375-1376	,	_	_	_	_
11-5	1377-1384	several	abstract[69]	new[69]	_	_
11-6	1385-1395	structural	abstract[69]	new[69]	_	_
11-7	1396-1404	features	abstract[69]	new[69]	_	_
11-8	1405-1407	of	abstract[69]	new[69]	_	_
11-9	1408-1412	DmxA	abstract[69]|abstract|abstract[71]	new[69]|giv|giv[71]	coref|coref|coref|coref	12-1[74_71]|15-16|12-1[74_71]|15-16
11-10	1413-1415	wt	abstract[69]|abstract[71]	new[69]|giv[71]	_	_
11-11	1416-1420	were	_	_	_	_
11-12	1421-1429	analyzed	_	_	_	_
11-13	1430-1432	in	_	_	_	_
11-14	1433-1439	detail	_	_	_	_
11-15	1440-1442	to	_	_	_	_
11-16	1443-1450	explain	_	_	_	_
11-17	1451-1454	its	abstract|abstract[73]	giv|giv[73]	coref|coref|coref|coref	15-29[103_73]|19-16[135_0]|15-29[103_73]|19-16[135_0]
11-18	1455-1468	extraordinary	abstract[73]	giv[73]	_	_
11-19	1469-1478	stability	abstract[73]	giv[73]	_	_
11-20	1479-1480	.	_	_	_	_

#Text=DmxA wt was found to form a dimer via a cysteine bridge , which may be formed only after heterologous expression in E. coli and purification , while is less likely to occur in the cytoplasm of the original host organism .
12-1	1481-1485	DmxA	abstract[74]	giv[74]	coref	15-17[0_74]
12-2	1486-1488	wt	abstract[74]	giv[74]	_	_
12-3	1489-1492	was	_	_	_	_
12-4	1493-1498	found	_	_	_	_
12-5	1499-1501	to	_	_	_	_
12-6	1502-1506	form	abstract	new	coref|none	15-20[101_0]|12-6[0_101]
12-7	1507-1508	a	object[75]	new[75]	_	_
12-8	1509-1514	dimer	object[75]	new[75]	_	_
12-9	1515-1518	via	object[75]	new[75]	_	_
12-10	1519-1520	a	object[75]|object[77]	new[75]|new[77]	coref	15-12[97_77]
12-11	1521-1529	cysteine	object[75]|place|object[77]	new[75]|new|new[77]	coref	16-13
12-12	1530-1536	bridge	object[75]|object[77]	new[75]|new[77]	_	_
12-13	1537-1538	,	_	_	_	_
12-14	1539-1544	which	_	_	_	_
12-15	1545-1548	may	_	_	_	_
12-16	1549-1551	be	_	_	_	_
12-17	1552-1558	formed	_	_	_	_
12-18	1559-1563	only	abstract[79]	new[79]	ana	13-1[0_79]
12-19	1564-1569	after	abstract[79]	new[79]	_	_
12-20	1570-1582	heterologous	person|abstract[79]	new|new[79]	_	_
12-21	1583-1593	expression	abstract[79]	new[79]	_	_
12-22	1594-1596	in	abstract[79]	new[79]	_	_
12-23	1597-1599	E.	abstract[79]	new[79]	_	_
12-24	1600-1604	coli	abstract[79]	new[79]	_	_
12-25	1605-1608	and	abstract[79]	new[79]	_	_
12-26	1609-1621	purification	abstract[79]|substance	new[79]|new	_	_
12-27	1622-1623	,	_	_	_	_
12-28	1624-1629	while	_	_	_	_
12-29	1630-1632	is	_	_	_	_
12-30	1633-1637	less	_	_	_	_
12-31	1638-1644	likely	_	_	_	_
12-32	1645-1647	to	_	_	_	_
12-33	1648-1653	occur	_	_	_	_
12-34	1654-1656	in	_	_	_	_
12-35	1657-1660	the	place[81]	new[81]	_	_
12-36	1661-1670	cytoplasm	place[81]	new[81]	_	_
12-37	1671-1673	of	place[81]	new[81]	_	_
12-38	1674-1677	the	place[81]|animal[82]	new[81]|new[82]	_	_
12-39	1678-1686	original	place[81]|animal[82]	new[81]|new[82]	_	_
12-40	1687-1691	host	place[81]|animal[82]	new[81]|new[82]	_	_
12-41	1692-1700	organism	place[81]|animal[82]	new[81]|new[82]	_	_
12-42	1701-1702	.	_	_	_	_

#Text=This is the first observation ever of HLD oligomerization mediated by the covalent bond .
13-1	1703-1707	This	abstract	giv	coref	13-3[84_0]
13-2	1708-1710	is	_	_	_	_
13-3	1711-1714	the	abstract[84]	giv[84]	_	_
13-4	1715-1720	first	abstract[84]	giv[84]	_	_
13-5	1721-1732	observation	abstract[84]	giv[84]	_	_
13-6	1733-1737	ever	abstract[84]	giv[84]	_	_
13-7	1738-1740	of	abstract[84]	giv[84]	_	_
13-8	1741-1744	HLD	abstract[84]|object|object[86]	giv[84]|giv|new[86]	coref|coref	20-1[141_0]|20-1[141_0]
13-9	1745-1760	oligomerization	abstract[84]|object[86]	giv[84]|new[86]	_	_
13-10	1761-1769	mediated	_	_	_	_
13-11	1770-1772	by	_	_	_	_
13-12	1773-1776	the	abstract[87]	new[87]	_	_
13-13	1777-1785	covalent	abstract[87]	new[87]	_	_
13-14	1786-1790	bond	abstract[87]	new[87]	_	_
13-15	1791-1792	.	_	_	_	_

#Text=Thus far , the reported dimers of DbjA and DbeA were formed through the hydrophobic interactions of C-terminal α-helices .
14-1	1793-1797	Thus	_	_	_	_
14-2	1798-1801	far	_	_	_	_
14-3	1802-1803	,	_	_	_	_
14-4	1804-1807	the	object[88]	new[88]	_	_
14-5	1808-1816	reported	object[88]	new[88]	_	_
14-6	1817-1823	dimers	object[88]	new[88]	_	_
14-7	1824-1826	of	object[88]	new[88]	_	_
14-8	1827-1831	DbjA	object[88]|abstract	new[88]|new	_	_
14-9	1832-1835	and	object[88]	new[88]	_	_
14-10	1836-1840	DbeA	object[88]|abstract	new[88]|new	_	_
14-11	1841-1845	were	_	_	_	_
14-12	1846-1852	formed	_	_	_	_
14-13	1853-1860	through	_	_	_	_
14-14	1861-1864	the	abstract[91]	new[91]	coref	23-35[176_91]
14-15	1865-1876	hydrophobic	abstract[91]	new[91]	_	_
14-16	1877-1889	interactions	abstract[91]	new[91]	_	_
14-17	1890-1892	of	abstract[91]	new[91]	_	_
14-18	1893-1903	C-terminal	abstract[91]|object[92]	new[91]|new[92]	_	_
14-19	1904-1913	α-helices	abstract[91]|object[92]	new[91]|new[92]	_	_
14-20	1914-1915	.	_	_	_	_

#Text=Although cysteines in protein structures often serve as stabilizing elements , the S-S bridge between DmxA wt units in its dimeric form did not have any effect on the stability or the activity of the enzyme .
15-1	1916-1924	Although	_	_	_	_
15-2	1925-1934	cysteines	substance[93]	new[93]	_	_
15-3	1935-1937	in	substance[93]	new[93]	_	_
15-4	1938-1945	protein	substance[93]|substance|abstract[95]	new[93]|giv|new[95]	coref|coref|coref|coref	23-39|28-20[217_95]|23-39|28-20[217_95]
15-5	1946-1956	structures	substance[93]|abstract[95]	new[93]|new[95]	_	_
15-6	1957-1962	often	_	_	_	_
15-7	1963-1968	serve	_	_	_	_
15-8	1969-1971	as	_	_	_	_
15-9	1972-1983	stabilizing	_	_	_	_
15-10	1984-1992	elements	_	_	_	_
15-11	1993-1994	,	_	_	_	_
15-12	1995-1998	the	object[97]	giv[97]	coref	16-12[112_97]
15-13	1999-2002	S-S	place|object[97]	new|giv[97]	_	_
15-14	2003-2009	bridge	object[97]	giv[97]	_	_
15-15	2010-2017	between	object[97]	giv[97]	_	_
15-16	2018-2022	DmxA	object[97]|event|organization[100]	giv[97]|giv|new[100]	coref|coref	17-8|17-8
15-17	2023-2025	wt	object[97]|abstract|organization[100]	giv[97]|giv|new[100]	coref	17-8[119_0]
15-18	2026-2031	units	object[97]|organization[100]	giv[97]|new[100]	_	_
15-19	2032-2034	in	object[97]|organization[100]	giv[97]|new[100]	_	_
15-20	2035-2038	its	object[97]|organization[100]|abstract[101]	giv[97]|new[100]|new[101]	_	_
15-21	2039-2046	dimeric	object[97]|organization[100]|abstract[101]	giv[97]|new[100]|new[101]	_	_
15-22	2047-2051	form	object[97]|organization[100]|abstract[101]	giv[97]|new[100]|new[101]	_	_
15-23	2052-2055	did	_	_	_	_
15-24	2056-2059	not	_	_	_	_
15-25	2060-2064	have	_	_	_	_
15-26	2065-2068	any	abstract[102]	new[102]	coref	23-30[174_102]
15-27	2069-2075	effect	abstract[102]	new[102]	_	_
15-28	2076-2078	on	abstract[102]	new[102]	_	_
15-29	2079-2082	the	abstract[102]|abstract[103]|abstract[104]	new[102]|giv[103]|new[104]	coref|coref	21-11[151_104]|21-11[151_104]
15-30	2083-2092	stability	abstract[102]|abstract[103]|abstract[104]	new[102]|giv[103]|new[104]	_	_
15-31	2093-2095	or	abstract[102]|abstract[104]	new[102]|new[104]	_	_
15-32	2096-2099	the	abstract[102]|abstract[104]|abstract[105]	new[102]|new[104]|new[105]	coref	33-53[278_105]
15-33	2100-2108	activity	abstract[102]|abstract[104]|abstract[105]	new[102]|new[104]|new[105]	_	_
15-34	2109-2111	of	abstract[102]|abstract[104]|abstract[105]	new[102]|new[104]|new[105]	_	_
15-35	2112-2115	the	abstract[102]|abstract[104]|abstract[105]|substance[106]	new[102]|new[104]|new[105]|giv[106]	coref	16-27[116_106]
15-36	2116-2122	enzyme	abstract[102]|abstract[104]|abstract[105]|substance[106]	new[102]|new[104]|new[105]|giv[106]	_	_
15-37	2123-2124	.	_	_	_	_

#Text=Furthermore , our experiments revealed that the presence or absence of such cysteine bridge neither influenced any of the catalytic properties nor the storage stability of the enzyme .
16-1	2125-2136	Furthermore	_	_	_	_
16-2	2137-2138	,	_	_	_	_
16-3	2139-2142	our	person|abstract[108]	acc|new[108]	ana|ana	26-2|26-2
16-4	2143-2154	experiments	abstract[108]	new[108]	_	_
16-5	2155-2163	revealed	_	_	_	_
16-6	2164-2168	that	_	_	_	_
16-7	2169-2172	the	abstract[109]	giv[109]	_	_
16-8	2173-2181	presence	abstract[109]	giv[109]	_	_
16-9	2182-2184	or	_	_	_	_
16-10	2185-2192	absence	abstract[110]	new[110]	_	_
16-11	2193-2195	of	abstract[110]	new[110]	_	_
16-12	2196-2200	such	abstract[110]|object[112]	new[110]|giv[112]	coref	18-3[126_112]
16-13	2201-2209	cysteine	abstract[110]|place|object[112]	new[110]|giv|giv[112]	_	_
16-14	2210-2216	bridge	abstract[110]|object[112]	new[110]|giv[112]	_	_
16-15	2217-2224	neither	_	_	_	_
16-16	2225-2235	influenced	_	_	_	_
16-17	2236-2239	any	_	_	_	_
16-18	2240-2242	of	_	_	_	_
16-19	2243-2246	the	abstract[113]	new[113]	_	_
16-20	2247-2256	catalytic	abstract[113]	new[113]	_	_
16-21	2257-2267	properties	abstract[113]	new[113]	_	_
16-22	2268-2271	nor	_	_	_	_
16-23	2272-2275	the	abstract[115]	new[115]	ana	17-1[0_115]
16-24	2276-2283	storage	place|abstract[115]	new|new[115]	_	_
16-25	2284-2293	stability	abstract[115]	new[115]	_	_
16-26	2294-2296	of	abstract[115]	new[115]	_	_
16-27	2297-2300	the	abstract[115]|substance[116]	new[115]|giv[116]	coref	17-22[123_116]
16-28	2301-2307	enzyme	abstract[115]|substance[116]	new[115]|giv[116]	_	_
16-29	2308-2309	.	_	_	_	_

#Text=It is also worth mentioning that the DmxA wt oligomer equilibrium varies in solution , and only a small part of the enzyme ( up to 30 % ) is present as a dimer .
17-1	2310-2312	It	abstract	giv	_	_
17-2	2313-2315	is	_	_	_	_
17-3	2316-2320	also	_	_	_	_
17-4	2321-2326	worth	_	_	_	_
17-5	2327-2337	mentioning	_	_	_	_
17-6	2338-2342	that	_	_	_	_
17-7	2343-2346	the	abstract[121]	new[121]	_	_
17-8	2347-2351	DmxA	abstract|abstract[119]|abstract[121]	giv|giv[119]|new[121]	coref|coref|coref|coref	19-12|19-13[0_119]|19-12|19-13[0_119]
17-9	2352-2354	wt	abstract[119]|abstract[121]	giv[119]|new[121]	_	_
17-10	2355-2363	oligomer	person|abstract[121]	new|new[121]	_	_
17-11	2364-2375	equilibrium	abstract[121]	new[121]	_	_
17-12	2376-2382	varies	_	_	_	_
17-13	2383-2385	in	_	_	_	_
17-14	2386-2394	solution	substance	new	_	_
17-15	2395-2396	,	_	_	_	_
17-16	2397-2400	and	_	_	_	_
17-17	2401-2405	only	_	_	_	_
17-18	2406-2407	a	_	_	_	_
17-19	2408-2413	small	_	_	_	_
17-20	2414-2418	part	_	_	_	_
17-21	2419-2421	of	_	_	_	_
17-22	2422-2425	the	substance[123]	giv[123]	coref	18-14[128_123]
17-23	2426-2432	enzyme	substance[123]	giv[123]	_	_
17-24	2433-2434	(	_	_	_	_
17-25	2435-2437	up	_	_	_	_
17-26	2438-2440	to	_	_	_	_
17-27	2441-2443	30	quantity[124]	new[124]	_	_
17-28	2444-2445	%	quantity[124]	new[124]	_	_
17-29	2446-2447	)	_	_	_	_
17-30	2448-2450	is	_	_	_	_
17-31	2451-2458	present	_	_	_	_
17-32	2459-2461	as	_	_	_	_
17-33	2462-2463	a	_	_	_	_
17-34	2464-2469	dimer	_	_	_	_
17-35	2470-2471	.	_	_	_	_

#Text=Therefore , the disulfide bridge does not contribute to the overall stability of the enzyme .
18-1	2472-2481	Therefore	_	_	_	_
18-2	2482-2483	,	_	_	_	_
18-3	2484-2487	the	object[126]	giv[126]	_	_
18-4	2488-2497	disulfide	substance|object[126]	giv|giv[126]	_	_
18-5	2498-2504	bridge	object[126]	giv[126]	_	_
18-6	2505-2509	does	_	_	_	_
18-7	2510-2513	not	_	_	_	_
18-8	2514-2524	contribute	_	_	_	_
18-9	2525-2527	to	_	_	_	_
18-10	2528-2531	the	abstract[127]	new[127]	ana	19-10[131_127]
18-11	2532-2539	overall	abstract[127]	new[127]	_	_
18-12	2540-2549	stability	abstract[127]	new[127]	_	_
18-13	2550-2552	of	abstract[127]	new[127]	_	_
18-14	2553-2556	the	abstract[127]|substance[128]	new[127]|giv[128]	coref	21-11[0_128]
18-15	2557-2563	enzyme	abstract[127]|substance[128]	new[127]|giv[128]	_	_
18-16	2564-2565	.	_	_	_	_

#Text=A unique composition of the catalytic pentad was observed both in DmxA wt sequence and crystal structure , containing a glutamine instead of the typical asparagine present in other members of the subfamily HLD-II .
19-1	2566-2567	A	abstract[129]	new[129]	_	_
19-2	2568-2574	unique	abstract[129]	new[129]	_	_
19-3	2575-2586	composition	abstract[129]	new[129]	_	_
19-4	2587-2589	of	abstract[129]	new[129]	_	_
19-5	2590-2593	the	abstract[129]|object[130]	new[129]|new[130]	_	_
19-6	2594-2603	catalytic	abstract[129]|object[130]	new[129]|new[130]	_	_
19-7	2604-2610	pentad	abstract[129]|object[130]	new[129]|new[130]	_	_
19-8	2611-2614	was	_	_	_	_
19-9	2615-2623	observed	_	_	_	_
19-10	2624-2628	both	abstract[131]	giv[131]	coref	21-11[150_131]
19-11	2629-2631	in	abstract[131]	giv[131]	_	_
19-12	2632-2636	DmxA	abstract[131]|abstract|abstract[134]	giv[131]|giv|new[134]	coref|coref	22-9|22-9
19-13	2637-2639	wt	abstract[131]|abstract|abstract[134]	giv[131]|giv|new[134]	coref	22-10
19-14	2640-2648	sequence	abstract[131]|abstract[134]	giv[131]|new[134]	_	_
19-15	2649-2652	and	abstract[131]	giv[131]	_	_
19-16	2653-2660	crystal	abstract[131]|abstract[135]	giv[131]|giv[135]	coref	22-9[160_135]
19-17	2661-2670	structure	abstract[131]|abstract[135]	giv[131]|giv[135]	_	_
19-18	2671-2672	,	_	_	_	_
19-19	2673-2683	containing	_	_	_	_
19-20	2684-2685	a	substance[136]	new[136]	coref	23-3[163_136]
19-21	2686-2695	glutamine	substance[136]	new[136]	_	_
19-22	2696-2703	instead	substance[136]	new[136]	_	_
19-23	2704-2706	of	substance[136]	new[136]	_	_
19-24	2707-2710	the	substance[136]	new[136]	_	_
19-25	2711-2718	typical	substance[136]	new[136]	_	_
19-26	2719-2729	asparagine	substance[136]|substance	new[136]|new	coref	23-6
19-27	2730-2737	present	substance[136]	new[136]	_	_
19-28	2738-2740	in	substance[136]	new[136]	_	_
19-29	2741-2746	other	substance[136]|person[138]	new[136]|giv[138]	_	_
19-30	2747-2754	members	substance[136]|person[138]	new[136]|giv[138]	_	_
19-31	2755-2757	of	substance[136]|person[138]	new[136]|giv[138]	_	_
19-32	2758-2761	the	substance[136]|person[138]|abstract[139]	new[136]|giv[138]|giv[139]	_	_
19-33	2762-2771	subfamily	substance[136]|person[138]|abstract[139]	new[136]|giv[138]|giv[139]	_	_
19-34	2772-2778	HLD-II	substance[136]|person[138]|abstract[139]|event	new[136]|giv[138]|giv[139]|giv	_	_
19-35	2779-2780	.	_	_	_	_

#Text=Another HLD with an unusual halide-stabilizing residue ( DatA containing tyrosine instead of tryptophan ) was described earlier .
20-1	2781-2788	Another	object[141]	giv[141]	_	_
20-2	2789-2792	HLD	object[141]	giv[141]	_	_
20-3	2793-2797	with	object[141]	giv[141]	_	_
20-4	2798-2800	an	object[141]|object[142]	giv[141]|new[142]	appos	20-9[0_142]
20-5	2801-2808	unusual	object[141]|object[142]	giv[141]|new[142]	_	_
20-6	2809-2827	halide-stabilizing	object[141]|object[142]	giv[141]|new[142]	_	_
20-7	2828-2835	residue	object[141]|object[142]	giv[141]|new[142]	_	_
20-8	2836-2837	(	_	_	_	_
20-9	2838-2842	DatA	object	giv	coref	21-5[148_0]
20-10	2843-2853	containing	_	_	_	_
20-11	2854-2862	tyrosine	substance	new	_	_
20-12	2863-2870	instead	_	_	_	_
20-13	2871-2873	of	_	_	_	_
20-14	2874-2884	tryptophan	substance	new	_	_
20-15	2885-2886	)	_	_	_	_
20-16	2887-2890	was	_	_	_	_
20-17	2891-2900	described	_	_	_	_
20-18	2901-2908	earlier	_	_	_	_
20-19	2909-2910	.	_	_	_	_

#Text=In this case , the unique halide stabilizing residue decreased enzyme stability ( by 3.5 °C ) and only moderately affected enzyme specificity .
21-1	2911-2913	In	_	_	_	_
21-2	2914-2918	this	abstract[146]	new[146]	coref	26-2[194_146]
21-3	2919-2923	case	abstract[146]	new[146]	_	_
21-4	2924-2925	,	_	_	_	_
21-5	2926-2929	the	object[148]	giv[148]	_	_
21-6	2930-2936	unique	object[148]	giv[148]	_	_
21-7	2937-2943	halide	substance|object[148]	new|giv[148]	_	_
21-8	2944-2955	stabilizing	object[148]	giv[148]	_	_
21-9	2956-2963	residue	object[148]	giv[148]	_	_
21-10	2964-2973	decreased	_	_	_	_
21-11	2974-2980	enzyme	object|abstract[150]|abstract[151]	giv|giv[150]|giv[151]	coref|coref|coref|coref|coref|coref	21-22|33-50[277_151]|21-22|33-50[277_151]|21-22|33-50[277_151]
21-12	2981-2990	stability	abstract[150]|abstract[151]	giv[150]|giv[151]	_	_
21-13	2991-2992	(	abstract[150]|abstract[151]	giv[150]|giv[151]	_	_
21-14	2993-2995	by	abstract[150]|abstract[151]	giv[150]|giv[151]	_	_
21-15	2996-2999	3.5	abstract[150]|abstract[151]|quantity[152]	giv[150]|giv[151]|new[152]	_	_
21-16	3000-3002	°C	abstract[150]|abstract[151]|quantity[152]	giv[150]|giv[151]|new[152]	_	_
21-17	3003-3004	)	abstract[150]|abstract[151]	giv[150]|giv[151]	_	_
21-18	3005-3008	and	abstract[151]	giv[151]	_	_
21-19	3009-3013	only	abstract[151]	giv[151]	_	_
21-20	3014-3024	moderately	abstract[151]	giv[151]	_	_
21-21	3025-3033	affected	abstract[151]	giv[151]	_	_
21-22	3034-3040	enzyme	abstract[151]|object|abstract[154]	giv[151]|giv|new[154]	coref|coref|coref|coref	23-12[167_0]|24-7[181_154]|23-12[167_0]|24-7[181_154]
21-23	3041-3052	specificity	abstract[151]|abstract[154]	giv[151]|new[154]	_	_
21-24	3053-3054	.	_	_	_	_

#Text=The position of the Q40 side chain in DmxA wt structure disables its functioning as a halide-stabilizing residue .
22-1	3055-3058	The	abstract[155]	new[155]	_	_
22-2	3059-3067	position	abstract[155]	new[155]	_	_
22-3	3068-3070	of	abstract[155]	new[155]	_	_
22-4	3071-3074	the	abstract[155]|object[157]	new[155]|new[157]	_	_
22-5	3075-3078	Q40	abstract[155]|place|object[157]	new[155]|new|new[157]	_	_
22-6	3079-3083	side	abstract[155]|object[157]	new[155]|new[157]	_	_
22-7	3084-3089	chain	abstract[155]|object[157]	new[155]|new[157]	_	_
22-8	3090-3092	in	abstract[155]|object[157]	new[155]|new[157]	_	_
22-9	3093-3097	DmxA	abstract[155]|object[157]|object|abstract[160]	new[155]|new[157]|giv|giv[160]	ana|coref|ana|coref	22-13[0_160]|24-16[185_0]|22-13[0_160]|24-16[185_0]
22-10	3098-3100	wt	abstract[155]|object[157]|abstract|abstract[160]	new[155]|new[157]|giv|giv[160]	coref	27-6
22-11	3101-3110	structure	abstract[155]|object[157]|abstract[160]	new[155]|new[157]|giv[160]	_	_
22-12	3111-3119	disables	_	_	_	_
22-13	3120-3123	its	abstract|abstract[162]	giv|new[162]	coref|coref	27-5[203_0]|27-5[203_0]
22-14	3124-3135	functioning	abstract[162]	new[162]	_	_
22-15	3136-3138	as	_	_	_	_
22-16	3139-3140	a	_	_	_	_
22-17	3141-3159	halide-stabilizing	_	_	_	_
22-18	3160-3167	residue	_	_	_	_
22-19	3168-3169	.	_	_	_	_

#Text=When replacing the glutamine with asparagine , the melting temperature of the enzyme decreased by 2 °C ( T m , app = 63.9 ± 0.2 °C ) confirming a small stabilizing effect of glutamine interactions in the protein core .
23-1	3170-3174	When	_	_	_	_
23-2	3175-3184	replacing	_	_	_	_
23-3	3185-3188	the	substance[163]	giv[163]	coref	23-35[0_163]
23-4	3189-3198	glutamine	substance[163]	giv[163]	_	_
23-5	3199-3203	with	substance[163]	giv[163]	_	_
23-6	3204-3214	asparagine	substance[163]|substance	giv[163]|giv	coref	33-37
23-7	3215-3216	,	_	_	_	_
23-8	3217-3220	the	abstract[166]	giv[166]	coref	30-16[238_166]
23-9	3221-3228	melting	object|abstract[166]	giv|giv[166]	coref	30-19
23-10	3229-3240	temperature	abstract[166]	giv[166]	_	_
23-11	3241-3243	of	abstract[166]	giv[166]	_	_
23-12	3244-3247	the	abstract[166]|substance[167]	giv[166]|giv[167]	coref	26-13[0_167]
23-13	3248-3254	enzyme	abstract[166]|substance[167]	giv[166]|giv[167]	_	_
23-14	3255-3264	decreased	_	_	_	_
23-15	3265-3267	by	_	_	_	_
23-16	3268-3269	2	quantity[168]	new[168]	appos	23-19[170_168]
23-17	3270-3272	°C	quantity[168]	new[168]	_	_
23-18	3273-3274	(	_	_	_	_
23-19	3275-3276	T	person|quantity[170]	giv|giv[170]	_	_
23-20	3277-3278	m	quantity[170]	giv[170]	_	_
23-21	3279-3280	,	_	_	_	_
23-22	3281-3284	app	quantity	giv	_	_
23-23	3285-3286	=	_	_	_	_
23-24	3287-3291	63.9	quantity[172]	new[172]	_	_
23-25	3292-3293	±	quantity[172]	new[172]	_	_
23-26	3294-3297	0.2	quantity[172]|quantity[173]	new[172]|new[173]	coref	30-13[0_173]
23-27	3298-3300	°C	quantity[172]|quantity[173]	new[172]|new[173]	_	_
23-28	3301-3302	)	_	_	_	_
23-29	3303-3313	confirming	_	_	_	_
23-30	3314-3315	a	abstract[174]	giv[174]	_	_
23-31	3316-3321	small	abstract[174]	giv[174]	_	_
23-32	3322-3333	stabilizing	abstract[174]	giv[174]	_	_
23-33	3334-3340	effect	abstract[174]	giv[174]	_	_
23-34	3341-3343	of	abstract[174]	giv[174]	_	_
23-35	3344-3353	glutamine	abstract[174]|substance|abstract[176]	giv[174]|giv|giv[176]	coref|coref|coref|coref	28-23[218_176]|33-35|28-23[218_176]|33-35
23-36	3354-3366	interactions	abstract[174]|abstract[176]	giv[174]|giv[176]	_	_
23-37	3367-3369	in	abstract[174]|abstract[176]	giv[174]|giv[176]	_	_
23-38	3370-3373	the	abstract[174]|abstract[176]|place[178]	giv[174]|giv[176]|new[178]	coref	30-7[233_178]
23-39	3374-3381	protein	abstract[174]|abstract[176]|substance|place[178]	giv[174]|giv[176]|giv|new[178]	coref	25-17
23-40	3382-3386	core	abstract[174]|abstract[176]|place[178]	giv[174]|giv[176]|new[178]	_	_
23-41	3387-3388	.	_	_	_	_

#Text=Moreover , an interesting shift in substrate specificity from SSG-I to SSG-IV was observed on the variant DmxA Q/N .
24-1	3389-3397	Moreover	_	_	_	_
24-2	3398-3399	,	_	_	_	_
24-3	3400-3402	an	abstract[179]	new[179]	_	_
24-4	3403-3414	interesting	abstract[179]	new[179]	_	_
24-5	3415-3420	shift	abstract[179]	new[179]	_	_
24-6	3421-3423	in	abstract[179]	new[179]	_	_
24-7	3424-3433	substrate	abstract[179]|person|abstract[181]	new[179]|new|giv[181]	coref|coref|coref|coref	25-5|25-4[189_181]|25-5|25-4[189_181]
24-8	3434-3445	specificity	abstract[179]|abstract[181]	new[179]|giv[181]	_	_
24-9	3446-3450	from	abstract[179]|abstract[181]	new[179]|giv[181]	_	_
24-10	3451-3456	SSG-I	abstract[179]|abstract[181]|abstract[182]	new[179]|giv[181]|new[182]	_	_
24-11	3457-3459	to	abstract[179]|abstract[181]|abstract[182]	new[179]|giv[181]|new[182]	_	_
24-12	3460-3466	SSG-IV	abstract[179]|abstract[181]|abstract[182]|abstract	new[179]|giv[181]|new[182]|new	_	_
24-13	3467-3470	was	_	_	_	_
24-14	3471-3479	observed	_	_	_	_
24-15	3480-3482	on	_	_	_	_
24-16	3483-3486	the	object[184]|object[185]	new[184]|giv[185]	coref|coref	27-5[0_185]|27-5[0_185]
24-17	3487-3494	variant	object[184]|object[185]	new[184]|giv[185]	_	_
24-18	3495-3499	DmxA	object[185]	giv[185]	_	_
24-19	3500-3503	Q/N	abstract	new	coref	35-9[291_0]
24-20	3504-3505	.	_	_	_	_

#Text=Such changes in the substrate specificity in HLDs are normally only be achieved after a sophisticated protein engineering .
25-1	3506-3510	Such	abstract[187]	new[187]	_	_
25-2	3511-3518	changes	abstract[187]	new[187]	_	_
25-3	3519-3521	in	abstract[187]	new[187]	_	_
25-4	3522-3525	the	abstract[187]|abstract[189]	new[187]|giv[189]	coref	26-15[0_189]
25-5	3526-3535	substrate	abstract[187]|person|abstract[189]	new[187]|giv|giv[189]	coref	26-14
25-6	3536-3547	specificity	abstract[187]|abstract[189]	new[187]|giv[189]	_	_
25-7	3548-3550	in	abstract[187]|abstract[189]	new[187]|giv[189]	_	_
25-8	3551-3555	HLDs	abstract[187]|abstract[189]|substance	new[187]|giv[189]|giv	coref	34-29[285_0]
25-9	3556-3559	are	_	_	_	_
25-10	3560-3568	normally	_	_	_	_
25-11	3569-3573	only	_	_	_	_
25-12	3574-3576	be	_	_	_	_
25-13	3577-3585	achieved	_	_	_	_
25-14	3586-3591	after	_	_	_	_
25-15	3592-3593	a	abstract[192]	new[192]	coref	31-1[239_192]
25-16	3594-3607	sophisticated	abstract[192]	new[192]	_	_
25-17	3608-3615	protein	substance|abstract[192]	giv|new[192]	coref	28-20
25-18	3616-3627	engineering	abstract[192]	new[192]	_	_
25-19	3628-3629	.	_	_	_	_

#Text=In our case , a single mutation was sufficient to shift the enzyme substrate specificity group .
26-1	3630-3632	In	_	_	_	_
26-2	3633-3636	our	person|abstract[194]	giv|giv[194]	ana|ana	32-5|32-5
26-3	3637-3641	case	abstract[194]	giv[194]	_	_
26-4	3642-3643	,	_	_	_	_
26-5	3644-3645	a	abstract[195]	new[195]	_	_
26-6	3646-3652	single	abstract[195]	new[195]	_	_
26-7	3653-3661	mutation	abstract[195]	new[195]	_	_
26-8	3662-3665	was	_	_	_	_
26-9	3666-3676	sufficient	_	_	_	_
26-10	3677-3679	to	_	_	_	_
26-11	3680-3685	shift	_	_	_	_
26-12	3686-3689	the	abstract[199]	new[199]	_	_
26-13	3690-3696	enzyme	substance|abstract[199]	giv|new[199]	coref	27-16
26-14	3697-3706	substrate	person|abstract[199]	giv|new[199]	_	_
26-15	3707-3718	specificity	abstract|abstract[199]	giv|new[199]	_	_
26-16	3719-3724	group	abstract[199]	new[199]	_	_
26-17	3725-3726	.	_	_	_	_

#Text=A deeper analysis of DmxA wt structure revealed an unusually small hydrophobic pocket containing the enzyme active site connected with the surrounding solvent by very narrow and closed tunnels .
27-1	3727-3728	A	abstract[200]	new[200]	_	_
27-2	3729-3735	deeper	abstract[200]	new[200]	_	_
27-3	3736-3744	analysis	abstract[200]	new[200]	_	_
27-4	3745-3747	of	abstract[200]	new[200]	_	_
27-5	3748-3752	DmxA	abstract[200]|object|abstract[203]	new[200]|giv|giv[203]	coref|coref|coref|coref	29-18[226_203]|32-19[251_0]|29-18[226_203]|32-19[251_0]
27-6	3753-3755	wt	abstract[200]|abstract|abstract[203]	new[200]|giv|giv[203]	coref	33-7[263_0]
27-7	3756-3765	structure	abstract[200]|abstract[203]	new[200]|giv[203]	_	_
27-8	3766-3774	revealed	_	_	_	_
27-9	3775-3777	an	abstract[204]	new[204]	_	_
27-10	3778-3787	unusually	abstract[204]	new[204]	_	_
27-11	3788-3793	small	abstract[204]	new[204]	_	_
27-12	3794-3805	hydrophobic	abstract[204]	new[204]	_	_
27-13	3806-3812	pocket	abstract[204]	new[204]	_	_
27-14	3813-3823	containing	_	_	_	_
27-15	3824-3827	the	place[206]	new[206]	coref	31-6[242_206]
27-16	3828-3834	enzyme	substance|place[206]	giv|new[206]	coref	30-17
27-17	3835-3841	active	place[206]	new[206]	_	_
27-18	3842-3846	site	place[206]	new[206]	_	_
27-19	3847-3856	connected	_	_	_	_
27-20	3857-3861	with	_	_	_	_
27-21	3862-3865	the	substance[207]	new[207]	coref	31-11[243_207]
27-22	3866-3877	surrounding	substance[207]	new[207]	_	_
27-23	3878-3885	solvent	substance[207]	new[207]	_	_
27-24	3886-3888	by	_	_	_	_
27-25	3889-3893	very	object[208]	new[208]	coref	31-3[240_208]
27-26	3894-3900	narrow	object[208]	new[208]	_	_
27-27	3901-3904	and	object[208]	new[208]	_	_
27-28	3905-3911	closed	object[208]	new[208]	_	_
27-29	3912-3919	tunnels	object[208]	new[208]	_	_
27-30	3920-3921	.	_	_	_	_

#Text=The presence of phenylalanine and methionine as bottleneck residues was not overly surprising since they often provide stabilization of protein structures via hydrophobic interactions .
28-1	3922-3925	The	abstract[209]	new[209]	_	_
28-2	3926-3934	presence	abstract[209]	new[209]	_	_
28-3	3935-3937	of	abstract[209]	new[209]	_	_
28-4	3938-3951	phenylalanine	abstract[209]|plant|abstract[211]	new[209]|new|new[211]	ana|ana	28-15[0_211]|28-15[0_211]
28-5	3952-3955	and	abstract[209]|abstract[211]	new[209]|new[211]	_	_
28-6	3956-3966	methionine	abstract[209]|abstract[211]|substance[212]	new[209]|new[211]|new[212]	_	_
28-7	3967-3969	as	abstract[209]|abstract[211]|substance[212]	new[209]|new[211]|new[212]	_	_
28-8	3970-3980	bottleneck	abstract[209]|abstract[211]|substance[212]|object	new[209]|new[211]|new[212]|new	coref	29-26
28-9	3981-3989	residues	abstract[209]|abstract[211]|substance[212]	new[209]|new[211]|new[212]	_	_
28-10	3990-3993	was	_	_	_	_
28-11	3994-3997	not	_	_	_	_
28-12	3998-4004	overly	_	_	_	_
28-13	4005-4015	surprising	_	_	_	_
28-14	4016-4021	since	_	_	_	_
28-15	4022-4026	they	abstract	giv	_	_
28-16	4027-4032	often	_	_	_	_
28-17	4033-4040	provide	_	_	_	_
28-18	4041-4054	stabilization	abstract[215]	new[215]	_	_
28-19	4055-4057	of	abstract[215]	new[215]	_	_
28-20	4058-4065	protein	abstract[215]|substance|abstract[217]	new[215]|giv|giv[217]	coref|coref	30-8|30-8
28-21	4066-4076	structures	abstract[215]|abstract[217]	new[215]|giv[217]	_	_
28-22	4077-4080	via	abstract[215]|abstract[217]	new[215]|giv[217]	_	_
28-23	4081-4092	hydrophobic	abstract[215]|abstract[217]|abstract[218]	new[215]|giv[217]|giv[218]	coref	29-22[0_218]
28-24	4093-4105	interactions	abstract[215]|abstract[217]|abstract[218]	new[215]|giv[217]|giv[218]	_	_
28-25	4106-4107	.	_	_	_	_

#Text=Replacement of bulky residues with alanines in the main tunnel opened the tunnel and suppressed stabilization of the tunnel structure via interactions provided by the bottleneck residues .
29-1	4108-4119	Replacement	event[219]	new[219]	_	_
29-2	4120-4122	of	event[219]	new[219]	_	_
29-3	4123-4128	bulky	event[219]|substance[220]	new[219]|new[220]	coref	29-25[229_220]
29-4	4129-4137	residues	event[219]|substance[220]	new[219]|new[220]	_	_
29-5	4138-4142	with	event[219]|substance[220]	new[219]|new[220]	_	_
29-6	4143-4151	alanines	event[219]|substance[220]|substance[221]	new[219]|new[220]|new[221]	_	_
29-7	4152-4154	in	event[219]|substance[220]|substance[221]	new[219]|new[220]|new[221]	_	_
29-8	4155-4158	the	event[219]|substance[220]|substance[221]|object[222]	new[219]|new[220]|new[221]|new[222]	coref	29-12[223_222]
29-9	4159-4163	main	event[219]|substance[220]|substance[221]|object[222]	new[219]|new[220]|new[221]|new[222]	_	_
29-10	4164-4170	tunnel	event[219]|substance[220]|substance[221]|object[222]	new[219]|new[220]|new[221]|new[222]	_	_
29-11	4171-4177	opened	_	_	_	_
29-12	4178-4181	the	object[223]	giv[223]	coref	29-19[0_223]
29-13	4182-4188	tunnel	object[223]	giv[223]	_	_
29-14	4189-4192	and	_	_	_	_
29-15	4193-4203	suppressed	_	_	_	_
29-16	4204-4217	stabilization	abstract[224]	new[224]	coref	31-23[245_224]
29-17	4218-4220	of	abstract[224]	new[224]	_	_
29-18	4221-4224	the	abstract[224]|abstract[226]	new[224]|giv[226]	_	_
29-19	4225-4231	tunnel	abstract[224]|object|abstract[226]	new[224]|giv|giv[226]	ana	30-1
29-20	4232-4241	structure	abstract[224]|abstract[226]	new[224]|giv[226]	_	_
29-21	4242-4245	via	abstract[224]|abstract[226]	new[224]|giv[226]	_	_
29-22	4246-4258	interactions	abstract[224]|abstract[226]|abstract	new[224]|giv[226]|giv	coref	32-27[254_0]
29-23	4259-4267	provided	_	_	_	_
29-24	4268-4270	by	_	_	_	_
29-25	4271-4274	the	substance[229]	giv[229]	_	_
29-26	4275-4285	bottleneck	object|substance[229]	giv|giv[229]	_	_
29-27	4286-4294	residues	substance[229]	giv[229]	_	_
29-28	4295-4296	.	_	_	_	_

#Text=This led to the destabilization of the protein core represented by 9 °C decrease of the enzyme apparent melting temperature .
30-1	4297-4301	This	object	giv	coref	33-41[274_0]
30-2	4302-4305	led	_	_	_	_
30-3	4306-4308	to	_	_	_	_
30-4	4309-4312	the	event[231]	new[231]	_	_
30-5	4313-4328	destabilization	event[231]	new[231]	_	_
30-6	4329-4331	of	event[231]	new[231]	_	_
30-7	4332-4335	the	event[231]|substance[233]	new[231]|giv[233]	_	_
30-8	4336-4343	protein	event[231]|substance|substance[233]	new[231]|giv|giv[233]	_	_
30-9	4344-4348	core	event[231]|substance[233]	new[231]|giv[233]	_	_
30-10	4349-4360	represented	_	_	_	_
30-11	4361-4363	by	_	_	_	_
30-12	4364-4365	9	event[235]	new[235]	_	_
30-13	4366-4368	°C	quantity|event[235]	giv|new[235]	_	_
30-14	4369-4377	decrease	event[235]	new[235]	_	_
30-15	4378-4380	of	event[235]	new[235]	_	_
30-16	4381-4384	the	event[235]|abstract[238]	new[235]|giv[238]	coref	34-22[284_238]
30-17	4385-4391	enzyme	event[235]|substance|abstract[238]	new[235]|giv|giv[238]	coref	31-7
30-18	4392-4400	apparent	event[235]|abstract[238]	new[235]|giv[238]	_	_
30-19	4401-4408	melting	event[235]|object|abstract[238]	new[235]|giv|giv[238]	coref	34-23
30-20	4409-4420	temperature	event[235]|abstract[238]	new[235]|giv[238]	_	_
30-21	4421-4422	.	_	_	_	_

#Text=Engineering of the tunnels connecting buried enzyme active site with the surrounding solvent has previously been described as a powerful strategy for enzyme stabilization .
31-1	4423-4434	Engineering	abstract[239]	giv[239]	_	_
31-2	4435-4437	of	abstract[239]	giv[239]	_	_
31-3	4438-4441	the	abstract[239]|object[240]	giv[239]|giv[240]	coref	32-8[248_240]
31-4	4442-4449	tunnels	abstract[239]|object[240]	giv[239]|giv[240]	_	_
31-5	4450-4460	connecting	_	_	_	_
31-6	4461-4467	buried	place[242]	giv[242]	_	_
31-7	4468-4474	enzyme	substance|place[242]	giv|giv[242]	coref	31-23
31-8	4475-4481	active	place[242]	giv[242]	_	_
31-9	4482-4486	site	place[242]	giv[242]	_	_
31-10	4487-4491	with	place[242]	giv[242]	_	_
31-11	4492-4495	the	place[242]|substance[243]	giv[242]|giv[243]	_	_
31-12	4496-4507	surrounding	place[242]|substance[243]	giv[242]|giv[243]	_	_
31-13	4508-4515	solvent	place[242]|substance[243]	giv[242]|giv[243]	_	_
31-14	4516-4519	has	_	_	_	_
31-15	4520-4530	previously	_	_	_	_
31-16	4531-4535	been	_	_	_	_
31-17	4536-4545	described	_	_	_	_
31-18	4546-4548	as	_	_	_	_
31-19	4549-4550	a	_	_	_	_
31-20	4551-4559	powerful	_	_	_	_
31-21	4560-4568	strategy	_	_	_	_
31-22	4569-4572	for	_	_	_	_
31-23	4573-4579	enzyme	substance|abstract[245]	giv|giv[245]	coref|coref|coref|coref	32-43[258_0]|33-29[269_245]|32-43[258_0]|33-29[269_245]
31-24	4580-4593	stabilization	abstract[245]	giv[245]	_	_
31-25	4594-4595	.	_	_	_	_

#Text=In this study , we proved that narrow tunnels play a crucial role in the paradoxical stability of DmxA due to multiple van der Waals and hydrophobic interactions , although they are not the only factor responsible for the unique properties of the enzyme .
32-1	4596-4598	In	_	_	_	_
32-2	4599-4603	this	abstract[246]	new[246]	_	_
32-3	4604-4609	study	abstract[246]	new[246]	_	_
32-4	4610-4611	,	_	_	_	_
32-5	4612-4614	we	person	giv	ana	33-14
32-6	4615-4621	proved	_	_	_	_
32-7	4622-4626	that	_	_	_	_
32-8	4627-4633	narrow	object[248]	giv[248]	_	_
32-9	4634-4641	tunnels	object[248]	giv[248]	_	_
32-10	4642-4646	play	_	_	_	_
32-11	4647-4648	a	abstract[249]	new[249]	_	_
32-12	4649-4656	crucial	abstract[249]	new[249]	_	_
32-13	4657-4661	role	abstract[249]	new[249]	_	_
32-14	4662-4664	in	_	_	_	_
32-15	4665-4668	the	abstract[250]	new[250]	_	_
32-16	4669-4680	paradoxical	abstract[250]	new[250]	_	_
32-17	4681-4690	stability	abstract[250]	new[250]	_	_
32-18	4691-4693	of	abstract[250]	new[250]	_	_
32-19	4694-4698	DmxA	abstract[250]|object[251]	new[250]|giv[251]	coref	33-11[0_251]
32-20	4699-4702	due	abstract[250]|object[251]	new[250]|giv[251]	_	_
32-21	4703-4705	to	_	_	_	_
32-22	4706-4714	multiple	object[252]	new[252]	_	_
32-23	4715-4718	van	object[252]	new[252]	_	_
32-24	4719-4722	der	object[252]|person[253]	new[252]|new[253]	_	_
32-25	4723-4728	Waals	object[252]|person[253]	new[252]|new[253]	_	_
32-26	4729-4732	and	_	_	_	_
32-27	4733-4744	hydrophobic	abstract[254]	giv[254]	ana	32-31[0_254]
32-28	4745-4757	interactions	abstract[254]	giv[254]	_	_
32-29	4758-4759	,	_	_	_	_
32-30	4760-4768	although	_	_	_	_
32-31	4769-4773	they	abstract	giv	_	_
32-32	4774-4777	are	_	_	_	_
32-33	4778-4781	not	_	_	_	_
32-34	4782-4785	the	abstract[256]	new[256]	_	_
32-35	4786-4790	only	abstract[256]	new[256]	_	_
32-36	4791-4797	factor	abstract[256]	new[256]	_	_
32-37	4798-4809	responsible	abstract[256]	new[256]	_	_
32-38	4810-4813	for	_	_	_	_
32-39	4814-4817	the	abstract[257]	new[257]	_	_
32-40	4818-4824	unique	abstract[257]	new[257]	_	_
32-41	4825-4835	properties	abstract[257]	new[257]	_	_
32-42	4836-4838	of	abstract[257]	new[257]	_	_
32-43	4839-4842	the	abstract[257]|abstract[258]	new[257]|giv[258]	coref	33-20[266_258]
32-44	4843-4849	enzyme	abstract[257]|abstract[258]	new[257]|giv[258]	_	_
32-45	4850-4851	.	_	_	_	_

#Text=To decipher the high stability of the new haloalkane dehalogenase DmxA wt , we investigated three unique features of the enzyme , corresponding to three possible sources of its stabilization . Both replacements of glutamine with asparagine and opening of the main tunnel brought desired outcomes in terms of decreased stability and improved activity .
33-1	4852-4854	To	_	_	_	_
33-2	4855-4863	decipher	_	_	_	_
33-3	4864-4867	the	abstract[259]	new[259]	_	_
33-4	4868-4872	high	abstract[259]	new[259]	_	_
33-5	4873-4882	stability	abstract[259]	new[259]	_	_
33-6	4883-4885	of	abstract[259]	new[259]	_	_
33-7	4886-4889	the	abstract[259]|abstract[263]	new[259]|giv[263]	ana	33-29[0_263]
33-8	4890-4893	new	abstract[259]|abstract[263]	new[259]|giv[263]	_	_
33-9	4894-4904	haloalkane	abstract[259]|object|abstract[263]	new[259]|new|giv[263]	_	_
33-10	4905-4917	dehalogenase	abstract[259]|abstract|abstract[263]	new[259]|new|giv[263]	_	_
33-11	4918-4922	DmxA	abstract[259]|abstract|abstract[263]	new[259]|giv|giv[263]	coref	35-9
33-12	4923-4925	wt	abstract[259]|abstract[263]	new[259]|giv[263]	_	_
33-13	4926-4927	,	_	_	_	_
33-14	4928-4930	we	person	giv	ana	34-9
33-15	4931-4943	investigated	_	_	_	_
33-16	4944-4949	three	abstract[265]	new[265]	_	_
33-17	4950-4956	unique	abstract[265]	new[265]	_	_
33-18	4957-4965	features	abstract[265]	new[265]	_	_
33-19	4966-4968	of	abstract[265]	new[265]	_	_
33-20	4969-4972	the	abstract[265]|substance[266]	new[265]|giv[266]	coref	34-13[281_266]
33-21	4973-4979	enzyme	abstract[265]|substance[266]	new[265]|giv[266]	_	_
33-22	4980-4981	,	_	_	_	_
33-23	4982-4995	corresponding	_	_	_	_
33-24	4996-4998	to	_	_	_	_
33-25	4999-5004	three	abstract[267]	new[267]	_	_
33-26	5005-5013	possible	abstract[267]	new[267]	_	_
33-27	5014-5021	sources	abstract[267]	new[267]	_	_
33-28	5022-5024	of	abstract[267]	new[267]	_	_
33-29	5025-5028	its	abstract[267]|abstract|abstract[269]	new[267]|giv|giv[269]	_	_
33-30	5029-5042	stabilization	abstract[267]|abstract[269]	new[267]|giv[269]	_	_
33-31	5043-5044	.	_	_	_	_
33-32	5045-5049	Both	event[270]	new[270]	_	_
33-33	5050-5062	replacements	event[270]	new[270]	_	_
33-34	5063-5065	of	event[270]	new[270]	_	_
33-35	5066-5075	glutamine	event[270]|substance	new[270]|giv	_	_
33-36	5076-5080	with	event[270]	new[270]	_	_
33-37	5081-5091	asparagine	event[270]|substance	new[270]|giv	_	_
33-38	5092-5095	and	event[270]	new[270]	_	_
33-39	5096-5103	opening	event[270]|event[273]	new[270]|new[273]	_	_
33-40	5104-5106	of	event[270]|event[273]	new[270]|new[273]	_	_
33-41	5107-5110	the	event[270]|event[273]|object[274]	new[270]|new[273]|giv[274]	_	_
33-42	5111-5115	main	event[270]|event[273]|object[274]	new[270]|new[273]|giv[274]	_	_
33-43	5116-5122	tunnel	event[270]|event[273]|object[274]	new[270]|new[273]|giv[274]	_	_
33-44	5123-5130	brought	_	_	_	_
33-45	5131-5138	desired	abstract[275]	new[275]	_	_
33-46	5139-5147	outcomes	abstract[275]	new[275]	_	_
33-47	5148-5150	in	abstract[275]	new[275]	_	_
33-48	5151-5156	terms	abstract[275]	new[275]	_	_
33-49	5157-5159	of	abstract[275]	new[275]	_	_
33-50	5160-5169	decreased	abstract[275]|abstract[276]|abstract[277]	new[275]|new[276]|giv[277]	_	_
33-51	5170-5179	stability	abstract[275]|abstract[276]|abstract[277]	new[275]|new[276]|giv[277]	_	_
33-52	5180-5183	and	abstract[275]|abstract[277]	new[275]|giv[277]	_	_
33-53	5184-5192	improved	abstract[275]|abstract[277]|abstract[278]	new[275]|giv[277]|giv[278]	_	_
33-54	5193-5201	activity	abstract[275]|abstract[277]|abstract[278]	new[275]|giv[277]|giv[278]	_	_
33-55	5202-5203	.	_	_	_	_

#Text=More importantly , introducing only two mutations , we managed to turn the thermostable enzyme into a mesophilic-like counterpart , with a melting temperature comparable to that of other related HLDs and a significantly improved catalytic performance .
34-1	5204-5208	More	_	_	_	_
34-2	5209-5220	importantly	_	_	_	_
34-3	5221-5222	,	_	_	_	_
34-4	5223-5234	introducing	_	_	_	_
34-5	5235-5239	only	abstract[279]	new[279]	coref	35-7[289_279]
34-6	5240-5243	two	abstract[279]	new[279]	_	_
34-7	5244-5253	mutations	abstract[279]	new[279]	_	_
34-8	5254-5255	,	_	_	_	_
34-9	5256-5258	we	person	giv	ana	35-2
34-10	5259-5266	managed	_	_	_	_
34-11	5267-5269	to	_	_	_	_
34-12	5270-5274	turn	_	_	_	_
34-13	5275-5278	the	substance[281]	giv[281]	coref	35-16[295_281]
34-14	5279-5291	thermostable	substance[281]	giv[281]	_	_
34-15	5292-5298	enzyme	substance[281]	giv[281]	_	_
34-16	5299-5303	into	_	_	_	_
34-17	5304-5305	a	abstract[282]	new[282]	_	_
34-18	5306-5321	mesophilic-like	abstract[282]	new[282]	_	_
34-19	5322-5333	counterpart	abstract[282]	new[282]	_	_
34-20	5334-5335	,	_	_	_	_
34-21	5336-5340	with	_	_	_	_
34-22	5341-5342	a	abstract[284]	giv[284]	_	_
34-23	5343-5350	melting	object|abstract[284]	giv|giv[284]	_	_
34-24	5351-5362	temperature	abstract[284]	giv[284]	_	_
34-25	5363-5373	comparable	abstract[284]	giv[284]	_	_
34-26	5374-5376	to	_	_	_	_
34-27	5377-5381	that	_	_	_	_
34-28	5382-5384	of	_	_	_	_
34-29	5385-5390	other	substance[285]	giv[285]	_	_
34-30	5391-5398	related	substance[285]	giv[285]	_	_
34-31	5399-5403	HLDs	substance[285]	giv[285]	_	_
34-32	5404-5407	and	_	_	_	_
34-33	5408-5409	a	abstract[286]	new[286]	_	_
34-34	5410-5423	significantly	abstract[286]	new[286]	_	_
34-35	5424-5432	improved	abstract[286]	new[286]	_	_
34-36	5433-5442	catalytic	abstract[286]	new[286]	_	_
34-37	5443-5454	performance	abstract[286]	new[286]	_	_
34-38	5455-5456	.	_	_	_	_

#Text=If we combined the effects of mutations in DmxA Q/N and DmxA MF/AA variants , the consequent enzyme would result in a highly active catalyst .
35-1	5457-5459	If	_	_	_	_
35-2	5460-5462	we	person	giv	_	_
35-3	5463-5471	combined	_	_	_	_
35-4	5472-5475	the	abstract[288]	new[288]	_	_
35-5	5476-5483	effects	abstract[288]	new[288]	_	_
35-6	5484-5486	of	abstract[288]	new[288]	_	_
35-7	5487-5496	mutations	abstract[288]|abstract[289]	new[288]|giv[289]	_	_
35-8	5497-5499	in	abstract[288]|abstract[289]	new[288]|giv[289]	_	_
35-9	5500-5504	DmxA	abstract[288]|abstract[289]|abstract|abstract[291]	new[288]|giv[289]|giv|giv[291]	coref|coref	35-12|35-12
35-10	5505-5508	Q/N	abstract[288]|abstract[289]|abstract[291]	new[288]|giv[289]|giv[291]	_	_
35-11	5509-5512	and	abstract[288]|abstract[289]	new[288]|giv[289]	_	_
35-12	5513-5517	DmxA	abstract[288]|abstract[289]|abstract|abstract[294]	new[288]|giv[289]|giv|new[294]	_	_
35-13	5518-5523	MF/AA	abstract[288]|abstract[289]|abstract|abstract[294]	new[288]|giv[289]|new|new[294]	_	_
35-14	5524-5532	variants	abstract[288]|abstract[289]|abstract[294]	new[288]|giv[289]|new[294]	_	_
35-15	5533-5534	,	_	_	_	_
35-16	5535-5538	the	substance[295]	giv[295]	_	_
35-17	5539-5549	consequent	substance[295]	giv[295]	_	_
35-18	5550-5556	enzyme	substance[295]	giv[295]	_	_
35-19	5557-5562	would	_	_	_	_
35-20	5563-5569	result	_	_	_	_
35-21	5570-5572	in	_	_	_	_
35-22	5573-5574	a	object[296]	new[296]	_	_
35-23	5575-5581	highly	object[296]	new[296]	_	_
35-24	5582-5588	active	object[296]	new[296]	_	_
35-25	5589-5597	catalyst	object[296]	new[296]	_	_
35-26	5598-5599	.	_	_	_	_
